Skill Checkup: A 69‐Year‐Old Woman With Acutely Worsening Heart Failure

Marco Guazzi, MD, PhD


March 21, 2022

The prevalence of iron deficiency in patients with HFpEF is approximately 50%, similar to that in patients with HFrEF, and contributes to worse functional outcomes, although without an impact on hospitalization and mortality.

Nevertheless, the prevalence of iron deficiency in patients with HFpEF, and its impact on functional outcomes, should alert the clinician to the importance of testing for iron deficiency in these patients. The FAIR-HF study is examining whether treatment of iron deficiency in patients with HFpEF can improve functional outcomes. Whether anemia or iron deficiency is the key driver of worsening symptoms and prognosis in patients with HF or whether each is important to the process is currently not known.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.